Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT03806881

Long Term Follow-up After Primary or Revision Shoulder Arthroplasty With a Patient- Specific Glenius Implant

This post-market follow-up study investigates improvement in clinical and radiological outcome after reversed total shoulder arthroplasty with the patient-specific Glenius Glenoid Reconstruction system

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

AZ St-Elisabeth, Herentals, Belgium

Loading trial locations.

About this study

The Glenius glenoid implant is a solution for patients who need a reversed glenoid reconstruction (primary or revision) because of a severely damaged glenoid associated with severe bone loss. In these cases, standard reconstruction of the glenoid is not possible because of the lack of body support of the glenoid rim or columns.

The Glenius implant is custom-made prothesis: during pre-operative planning, the implant is designed based on a detailed 3D CT analysis of the defect with special reference to bone quality and the anatomy of the bone deficient glenoid. Optimized screw fixation trajectories are defined for each individual patient, which accommodate screws that are positioned and angled towards the best bone stock available in the glenoid/coracoid/scapula with each specific patient. The surgeon provides feedback on the the design and orientation of the implant needed to achieve the optimal inclination of the head and the position & offset of the joint's centre of rotation.

Because Glenius is a relatively new product and only for use in specific and complex cases of severy glenoid erosion, follow-up data on the clinical and radiological outcome are scarce. With this study we aim to collect long-term clinical and radiological follow-up data for patients treated with Glenius in a uniform, standardized way.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients having primary or revision shoulder joint replacement with severe glenoid bone defects
  • Patient is 18 years of age or older
  • Patient can follow the Glenius system procedure that is standard of care
  • Patient is willing to cooperate in the required post-operative therapy
  • Patient has participated in the informed consent process and has signed the EC approved informed consent form

Exclusion criteria

  • Pregnant patients
  • Skeletally immature patients
  • Prisoners

Treatment and study plan

reversed glenoid prothesis

Device

All patients will undergo a primary or revision arthroplasty with Glenius according to the routine practice at the investigation site and will be followed at specified visiting moments, during which radiological and clinical data will be gathered.

Other names: Glenius Glenoid Reconstruction system

Primary outcomes

  1. Change in baseline Constant-Murley Score after surgery

    Time frame: 6 weeks, 3 months, 1 year, 2 year, 5 years after surgery

    The Constant-Murley score is a clinical outcome scale composed of a number of individual parameters, defining the level of pain, the ability to carry out the normal daily activities of the patient, mobility and strength of the arm. The scores range from 0 (worst clinical outcome) to 100 (best clinical outcome).

Secondary outcomes

  1. Change in baseline Simple Shoulder Test (SST) after surgery

    Time frame: 6 weeks, 3 months, 1 year, 2 year, 5 years after surgery

    The SST is a function scale with 12 items, used to assess improvement in shoulder function after treatment interventions and to check the patient's ability to tolerate or perform 12 activities of daily living. The scores range from 0 (worst functional outcome) to 100 (best functional outcome).

  2. Change in baseline Oxford Shoulder Score (OSS) after surgery

    Time frame: 6 weeks, 3 months, 1 year, 2 year, 5 years after surgery

    The OSS is a 12-item patient-reported outcome specifically designed and developed for assessing outcomes of shoulder surgery e.g. for assessing the impact on patients' quality of life of degenerative conditions such as arthritis and rotator cuff problems. The score ranges from 0 (no pain or functional impairement) to 60 (worst pain and functional impairement).

  3. change in general health EQ5D score after surgery

    Time frame: 6 weeks, 3 months, 1 year, 2 year, 5 years after surgery

    EQ-5D is a standardized patient-reported outcome for measuring generic health status. The questionnaire has two components: a health state description measured in terms of five dimensions (5D); mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. and a general evaluation of their overall health status using the visual analogue scale (EQ-VAS).

  4. change in baseline pain score using Visual Analogue Scales (VAS) after surgery

    Time frame: 6 weeks, 3 months, 1 year, 2 year, 5 years after surgery

    The VAS pain score is a patient-reported evaluation of pain intensity on a Visual Analogue Scales (VAS) between 0 (no pain) and 100 (worst pain imaginable).

  5. Translational deviation from planned implant position

    Time frame: 6 weeks after surgery

    translational deviation (in mm) of the implant position on post-operative shoulder CT scan when compared to the planned position on the pre-operative CT scan.

  6. Rotational deviation from planned implant position

    Time frame: 6 weeks after surgery

    Rotational deviation (in degrees) of the implant position on post-operative shoulder CT scan when compared to the planned position on the pre-operative CT scan.

  7. Translational deviation from initial implant position

    Time frame: 1 year after surgery

    translational deviation (in mm) on a shoulder CT scan 1 year after surgery, compared to the position on the post-operative CT scan.

  8. Rotational deviation from initial implant position

    Time frame: 1 year after surgery

    Rotational deviation (in degrees) on a shoulder CT scan 1 year after surgery, compared to the position on the post-operative CT scan.

  9. Scapular notching

    Time frame: 6 weeks, 3 months, 1 year, 2 years, 5 years after surgery

    scapular notching will be graded according to the Sirveaux classification system (2004) on a shoulder radiograph. The classification goes from 0 (no notching) to 4 (erosion over the inferior screw with extension under the baseplate)

  10. Radiolucensies

    Time frame: 6 weeks, 3 months, 1 year, 2 years, 5 years after surgery

    Radiolucencies surrounding the glenoid component will be graded according to the system of Lazarus (Lazarus et al 2002) on a shoulder radiograph. The classification goes from 0 (no lucensies) to 5 (gross lucensies and radiographic loosening)

  11. Heterotopic ossifications

    Time frame: 6 weeks, 3 months, 1 year, 2 years, 5 years after surgery

    periarticular heterotopic ossification (HO) will be scored according to a modified Brooker classification system of HO of the hip (Verhofste et al 2016) on a shoulder radiograph. The classification goes from 0 (no ossifications) to 3 (complete ankylosis of the shoulder)

  12. rate of implant revision surgeries up to 5 years after surgery

    Time frame: up to 5 years after surgery

    Implant survival will be calculated by calculating the rate of implant revision surgeries up to 5 years after surgery.

  13. Complication rate

    Time frame: up to 5 year after surgery

    the number and kind of (severe) adverse (device) events: device/shoulder related A(D)Es, SA(D)Es and device deficiencies that could have led to an SAE will be collected.

Sponsors and collaborators

Lead sponsor

Materialise

Industry

Registry information

Official study title

Long Term Follow-up After Primary or Revision Shoulder Arthroplasty With a Patient- Specific Glenius Implant: A Prospective Cohort Study

Important dates

Study start
2019
Primary completion
2024
Study completion
2028
First posted
Jan 16, 2019
Registry last updated
Mar 13, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.